This research study is evaluating an investigational medication when used with standard-of-care medication for adults with active IIM. You may be able to take part in this study if you:
Are at least 18 years of age
Have active IIM confirmed by a physician (such as a rheumatologist, neurologist, or dermatologist)
Are taking standard-of-care medication to treat your active IIM
Meet at least 1 of the following criteria at screening:
This study will evaluate the safety and efficacy of an investigational medication (a medication not approved for clinical use) when used with standard-of-care medications for adults with active IIM.
The study will involve study visits every 2 weeks over the course of up to 112 weeks, or about 26 months. About 200 participants will be enrolled, and they may be compensated for study-required travel and expenses.
If eligible, participation can last about 26 months.
The investigational medication in this study is a liquid solution administered via IV infusion (through a vein).
Do not discontinue any medication unless you are advised to do so by the study center staff or your primary care physician.
There is no cost to you for participating in the study.
Clinical research studies are designed in specific ways, and one or more of the answers that you provided were outside of the guidelines for this study. This does not mean you will not qualify for different research studies.
